Quantitative molecular virology in patient management

Journal of Clinical Pathology

Volumn 53, Issue 1, 2000, Pages 76-83

  Preiser, Wolfgang ^a   Elzinger, Bianca ^a   Brink, Nicola S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL THERAPY; ASSAY; DNA HYBRIDIZATION; GENE AMPLIFICATION; NUCLEIC ACID PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW; VIRUS GENOME; VIRUS INFECTION; VIRUS INFECTIVITY;

DNA, VIRAL; GENETIC MARKERS; GENETIC TECHNIQUES; GENOME, VIRAL; HUMANS; PROGNOSIS; RNA, VIRAL; VIRUS DISEASES;

EID: 0033961679     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.53.1.76     Document Type: Review

References (37)

1. Hammond J, Calef C, Larder B, et al. Mutations in retroviral genes associated with drug resistance. In: Korber B, Kuiken C, Foley B, et al, eds. Human retroviruses and AIDS 1998: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos: Theoretical Biology and Biophysics Group T-10, 1998:III-36-79.
2. Hawkins AE, Zuckerman MA, Briggs M, et al. Hepatitis B nucleotide sequence analysis: linking an outbreak of acute hepatitis B to contamination of a cryopreservation tank. J Virol Methods 1996;60:81-8.
3. Smith DB, Lawlor E, Power J, et al. A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland. Vox Sanguinis 1998;76:175-80.
4. Hodinka RL. The clinical utility of viral quantification using molecular methods. Clin Diagn Virol 1998;10:25-47.
5. Lock MJ, Griffiths PD, Emery VC. Development of a quantitative polymerase chain reaction for human herpesvirus 8. J Virol Methods 1997;64:19-26.
6. Ravaggi A, Zonaro A, Mazza C, et al. Quantitation of hepatitis C RNA by competitive amplification of RNA from denatured serum and hybridisation on microtitre plates. J Clin Microbiol 1995;33:265-9.
7. Whitby K, Garson JA. Optimisation and evaluation of a quantitative chemiluminescent polvmerase chain reaction assay for hepatitis C RNA. J Virol Methods 1995;51:75-88.
8. Ho DD, Tarsem M, Masud A. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-5.
9. Semple MG, Kaye S, Loveday C, et al. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol 1991:35:38-45
10. Cao Y, Qin L, Zhang L, et al. Virologic and immunologic characterisation of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332: 201-8.
11. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
12. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
13. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N Engl J Med 1997;336: 1337-42.
14. Kidd IM, Fox JC, Pillay D, et al. Provision of prognostic information in immunocompromised patients by routine application of polymerase chain reaction for cytomegalovirus. Transplantation 1993;56:867-71.
15. Fox JC, Kidd IM, Griffiths PD, et al. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol 1995;76:309-19.
16. Gor D, Sabin C, Prentice HG, et al. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/ recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant 1998;21:597-605.
17. Bowen EF, Sabin CA, Wilson P, et al. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS 1997;11:889-93.
18. Riddler SA, Breinig MC, McKnight JLC. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid organ transplant recipients. Blood 1994;84:972-84.
19. Yamamoto M, Kimura H, Hironaka T, et al. Detection and quantitation of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol 1995;33:1765-8.
20. Clark DA, Ait-Khalid M, Wheeler AC. Quantification of human herpesvirus 6 in immunocompetent and post-mortem tissues from AIDS patients by OCR. J Gen Virol 1996;77:2271-5.
21. Kidd IM, Clark DA, Ait-Khaled M, et al. Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction. J Infect Dis 1996;174:396-401.
22. Ahmed MM, Mutimer DJ, Martin B, et al. Hepatitis C viral load, genotype and histological severity in patients with bleeding disorders. Haemophilia 1999;5:49-55.
23. Baker BL, Di-Bisceglie AM, Kaneko S, et al. Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with clinical and biochemical markers. Hepatology 1991;13:632-6.
24. Berger A, Braner J, Doerr HW, et al. Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Intervirology 1997;41:24-34.
25. Saag MS, Holodniy M, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nature Med 1996;2:625-9.
26. Churchill D, Weber J. Measurement of plasma HIV viral load. J Infect 1999;38:147-50.
27. Garson JA, Brillanti S, Whitby K, et al. Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C. J Virol Methods 1995;45:348-53.
28. Garson JA, Uhnoo I, Whitby K, et al. Virological, biochemical and histological effects of human lymphoblastoid interferon in Swedish patients with chronic hepatitis C. J Viral Hepatitis 1997;4:325-31.
29. EASL International Consensus Conference on Hepatitis C. Paris 26-28 February 1999. Consensus Statement. J Hepatol 1999;30:956-61.
30. Walsh KM, Good T, Cameron S, et al. Viral kinetics can predict early response to alpha-interferon in chronic hepatitis C. Liver 1998;18:191-5.
31. Dusheiko GM, Khakoo S, Soni P, et al. A rational approach to the management of hepatitis C infection. BMJ 1996;312:357-64.
32. Thomas SL, Newell ML, Peckham CS, et al. A review of hepatitis C (HCV) vertical transmission: risks of transmission to infants born with and without HCV viraemia and human immunodeficiency virus infection. Int J Epidemiol 1998;27:1208-17.
33. Tovo PA, Palomba E, Ferraris G, et al. Increased risk of maternal-infant hepatitis C transmission for women co-infected with human immunodeficiency virus type 1. Italian Study Group for HCV infection in Children. Clin Infect Dis 1997;25:1121-4.
34. Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995;14:195-9.
35. Cao Y, Krogstad P, Korber BT, et al. Maternal HIV viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nature Med 1997;3:549-52.
36. Ragni MV, Faruki H, Kingsley LA. Heterosexual HIV-1 transmission and viral load in hemophilic patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:42-5.
37. Health Service Guidelines. Protecting health care workers and patients from hepatitis B. London: department of Health, 1993 [HSG(93)40:19931-3].